Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. The product will be commercialized from
About
Contact:
Mr.
Tel: +91-22-66888 404
Email: pradeep.bhandari@unichemlabs.com
Disclaimer
This press release includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ serially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.
(C) 2021 Electronic News Publishing, source